Pharmaco - Press Releases

Date	Title	Company
23-Jun-2021	Copley Scientific joins the Industries Forum of the Taskforce for Lung Health	Copley Scientific
23-Jun-2021	DARZALEX®▼ (daratumumab) Subcutaneous (SC) Formulation Becomes the First Approved Treatment for Newly Diagnosed Systemic Light Chain Amyloidosis in Europe and Gains an Additional Approval in Pre-Treated Multiple Myeloma	Janssen Pharmaceutical Companies of Johnson & Johnson
23-Jun-2021	Chiesi accelerates path toward full sustainability despite Covid-19 pandemic	Chiesi
23-Jun-2021	Advanced Biological Laboratories Obtained a Derogatory Authorization from the French National Agency for Medicines and Health Products Safety (ANSM) for its UltraGene Assay SARS-CoV-2 452R & 484K & 484Q Mutations	Advanced Biological Laboratories (ABL)
23-Jun-2021	SmiLe alumnus GPX Medical sold its first NEOLA® system	SmiLe Incubator
23-Jun-2021	Extension to proven TriMix® adjuvant technology intended to boost dendritic cell activation	eTheRNA immunotherapies NV
23-Jun-2021	Sosei Heptares Initiates Phase 1 Trial with Novel Small-Molecule CGRP Antagonist under Collaboration with Biohaven	Sosei Group Corporation
23-Jun-2021	HUTCHMED announces savolitinib approved in China for patients with lung cancer with MET exon 14 skipping alterations	HUTCHMED
23-Jun-2021	Genmab Announces that Janssen has Received European Marketing Authorizations for DARZALEX® (daratumumab) Subcutaneous Formulation, Including for the Treatment of Patients with Newly Diagnosed Light-chain (AL) Amyloidosis	Genmab
23-Jun-2021	LEO Pharma announces MHRA and EC approval of Adtralza▼ (tralokinumab) as the first and only treatment specifically targeting IL-13 only for adults with moderate-to-severe atopic dermatitis who are candidates for systemic therapy	LEO Pharma
23-Jun-2021	ProBioGen and LAVA Therapeutics N.V. Sign Agreement for Cell Line Development for Manufacturing of a Novel Bispecific	ProBioGen
23-Jun-2021	Santhera’s Shareholders Approve all Board Proposals at Today’s Annual General Meeting	Santhera Pharmaceuticals
23-Jun-2021	Breakthrough for data sector as Nimble Learn announces launch of analysis-ready Open Data Blend	Nimble Learn
23-Jun-2021	EVERSANA™ expands medical information and integrated compliance services across Europe	EVERSANA™
23-Jun-2021	Gilead’s Veklury® (Remdesivir) Associated With a Reduction in Mortality Rate in Hospitalized Patients With COVID-19 Across Three Analyses of Large Retrospective Real-World Data Sets	Gilead
23-Jun-2021	Jardiance® (empagliflozin) approved in Europe for the treatment of heart failure with reduced ejection fraction	Boehringer Ingelheim
23-Jun-2021	Orpathys approved in China for patients with lung cancer and MET gene alterations	AstraZeneca
23-Jun-2021	Koselugo approved in the EU for children with neurofibromatosis type 1 and plexiform neurofibromas	AstraZeneca
23-Jun-2021	Biotage Launches New Automated Platform for Plasmid DNA Purification	Biotage
23-Jun-2021	Coriolis Pharma Expands its ATMP Development Facilities	Coriolis Pharma